&nbsp;

Breast-Screen-Saver-and-Slide_English.zip

New

May 2025

Document

Breast-Screen-saver-and-Slide_French.zip

New

May 2025

Document

Breast-Screen-saver-and-Slide_Other Languages.zip

New

May 2025

Document

Breast-Postcard-Other-Languages.zip

New

May 2025

Regimen

ENHE

Cancer Type:

Breast

Intent: Palliative

Funding:

New Drug Funding Program

Trastuzumab Deruxtecan - Unresectable Locally Advanced or Metastatic Breast Cancer

New Drug Funding Program

Trastuzumab Deruxtecan - HER2-low Unresectable Locally Advanced or Metastatic Breast Cancer

Enhertu trastuzumab deruxtecan

Drugs Used:

Quick Link(s):

Regimen Monograph

May 2025

Regimen

ENHE

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Drugs Used:

Enhertu trastuzumab deruxtecan (Unfunded)

Quick Link(s):

Regimen Monograph

May 2025

Regimen

ENHE

Cancer Type:

Gastrointestinal,

Gastric / Stomach

Intent: Palliative

Funding:

New Drug Funding Program

Trastuzumab Deruxtecan - Previously Treated Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Enhertu trastuzumab deruxtecan

Drugs Used:

Quick Link(s):

Regimen Monograph

May 2025

Regimen

BORTDEXALENA+DARA(SC); LENA+DARA(MNT-SC)

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

New Drug Funding Program

Bortezomib - Previously Untreated - Multiple Myeloma Pre-Stem Cell Transplant

ODB - General Benefit

dexamethasone

Drugs Used:

daratumumab (subcut) (Unfunded),

bortezomib (Unfunded),

lenalidomide (Unfunded),

dexamethasone

Quick Link(s):

Regimen Monograph

May 2025

Regimen

BrECADD

Cancer Type:

Hematologic,

Lymphoma - Hodgkin

Intent: Curative

Funding:

ODB - General Benefit

dexamethasone

Drugs Used:

brentuximab vedotin (Unfunded),

Quick Link(s):

Regimen Monograph

May 2025

Regimen

BLIN

Cancer Type:

Hematologic,

Leukemia - Acute Lymphoblastic (ALL)

Intent: Curative, Palliative

Drugs Used:

blinatumomab (Compassionate)